Nice job, management.
OK, Liilly had a deal going with Amylin for Byetta, and then we dumped Amylin to get a deal with Boeringer Ingelheim?
So, Bristol Meyers bought Amylin because they're a good deal? And a bigger drug company pitched in?
The main problem with Lilly is they think they are smarter than everyone else.
OK, Liilly had a deal going with Amylin for Byetta, and then we dumped Amylin to get a deal with Boeringer Ingelheim?
So, Bristol Meyers bought Amylin because they're a good deal? And a bigger drug company pitched in?
The main problem with Lilly is they think they are smarter than everyone else.
We will end up paying dearly for this crappy decision.....
You are missing the point dear fellow. The Haaavaad endowment is $10M dollar richer for every year of the status quo. Cheer up!